Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography

The need for remyelinating drugs is essential for healing disabling diseases such as multiple sclerosis (MS). One of the reasons for the lack of this class of therapies is the impossibility to monitor remyelination in vivo, which is of utmost importance to perform effective clinical trials. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Benítez-Fernández, Rocío, Melero-Jerez, Carolina, Gil, Carmen, de la Rosa, Enrique J., Martínez, Ana, de Castro, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957639/
https://www.ncbi.nlm.nih.gov/pubmed/33671012
http://dx.doi.org/10.3390/ijms22052440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957639/
https://www.ncbi.nlm.nih.gov/pubmed/33671012
http://dx.doi.org/10.3390/ijms22052440

Ejemplares similares